Get your calendars, because the new 2027 EMBL Annual Poster has arrived: s.embl.org/2027-poster Whether you'd like to enhance your skills in a practical course or engage with the latest research at one of our conferences, we've got you covered. See you at EMBL in 2027! 🙌 #LifeSciences #EMBL

Celebrating 3 birthdays!💯🫯💢🎉🎊🧨

I am present in spirit! #Caldasians geeting together to celebrate the graduation of @allanlui.bsky.social from @caldaslab.bsky.social in Cambridge. Beautiful people from a great lab! #Caldasians now growing @hebrewuniversity.bsky.social! All the same spirit: making discoveries and enjoying life!

@caldaslab.bsky.social now based @lautenbergc.bsky.social @hebrewuniversity.bsky.social lab outing in Tel Aviv.

1/4 This is a rather bizarre framing of the debate. One thing is quite clear, those with a financial conflict of interest in recommending screening (radiologists) should have no say whatsoever. CoI (financial or professional) is not mentioned in the article.

JAMA@jama.com · 3w ago

#MedNews: Who should write breast cancer screening guidelines—disease specialists or primary care and evidence experts? As new recommendations fuel debate among medical organizations, the answer could affect how and when women are screened.

Fantastic to see our paper recently published @natureportfolio.nature.com Scientific Reports highlighted by Hartwig Medical Foundation! @caldaslab.bsky.social together with @ruedalab.bsky.social! My lab is now based @lautenbergc.bsky.social Faculty of Medicine of @hebrewuniversity.bsky.social

New study using Hartwig Medical Foundation data maps how breast cancer's genetic makeup shifts when it spreads - Hartwig Medical Foundation

Analysis of nearly 1,300 tumor genomes across ten genomic subtypes points to candidate drug targets and biomarkers for metastatic breast …

hartwigmedicalfoundation.nl

@helloeacr.bsky.social highlights of the EACR Cancer Genomics, Multiomics and Computational Biology Conference held in Essen in May. @caldaslab.bsky.social work featured prominently! Thanks to all #Caldasians and their outstanding work along the years! magazine.eacr.org/scientific-h...

Scientific Highlights from ‘Cancer Genomics, Multiomics and Computational Biology’ 2026 - The Cancer Researcher

'Cancer Genomics, Multiomics and Computational Biology' centred on integrating high-resolution genomic and multi-omic data with advanced computational and AI-driven approaches.

magazine.eacr.org

Just out! Another piece of amazing work from @caldaslab.bsky.social! www.nature.com/articles/s41...

This specific paper transformed the understanding of EP300 from a general transcriptional co-activator into a definitive cancer-preventing gene by proving it follows Knudson's "two-hit" hypothesis! 500 citations! @caldaslab.bsky.social h walking the walk for over 25y! www.nature.com/articles/ng0...

Mutations truncating the EP300 acetylase in human cancers - Nature Genetics

Nature Genetics - Mutations truncating the EP300 acetylase in human cancers

nature.com

Just out! Another piece of amazing work from @caldaslab.bsky.social! www.nature.com/articles/s41...

Some @caldaslab.bsky.social looking pretty happy! We are delighted to be at the Concern Foundation Laboratories @lautenbergc.bsky.social located in the Faculty of Medicine @hebrewuniversity.bsky.social! Walking the walk and making discoveries!

Looking forward to a great opportunity for @hebrewuniversity.bsky.social Faculty of Medicine to brainstorm about cancer within #HUCMED!

Fantastic to see in this major paper www.nature.com/articles/s41... validation of CNA hits uses #METABRIC!! Impactful research from @caldaslab.bsky.social being cited 14 years later!

Aneuploidy selects for the acquisition of driver genes in breast cancer - Nature

Screening of chromosome arm-level aneuploidies uncovers that these alterations select for specific basal-like breast cancer driver genes, including PLGRKT, an oncogene whose tumour-promoting activity ...

nature.com

Davidson Cancer Center visited July 1. Impressive place! Gave seminar on our concept: 'Precision Breast Cancer Medicine 2.0'. Multi-omics integrated with ML/AL/AI where better cancer management hinges! @caldaslab.bsky.social has been pioneering it for years. Walking the walk where others just talk!

Could be the @caldaslab.bsky.social moto! With hard work we have recreated a lab driven by curiosity and the fight against cancer! @lautenbergc.bsky.social based in the @hebrewuniversity.bsky.social Faculty of Medicine.

Could not agree more! Proud to serve as an Honorary Consultant Medical Oncologist @cuh.nhs.uk since 1996!

Paul Pharoah@paulpharoah.bsky.social · last mo.

The NHS is a great institution; a national treasure. That does not mean it is without faults.

Very nice to see this in press! @caldaslab.bsky.social walks the walk! Thanks to Eytan Rupin for involving us! Predicting neoadjuvant breast cancer therapy response using BRIDGE from tumor transcriptomics and histopathology - Annals of Oncology www.annalsofoncology.org/article/S092...

Predicting neoadjuvant breast cancer therapy response using BRIDGE from tumor transcriptomics and histopathology

While expression-based signatures inform adjuvant therapy in breast cancer (BC), no approved molecular biomarkers exist for the neoadjuvant setting, where early response prediction could inform treatm...

annalsofoncology.org

Very nice to see this in press! @caldaslab.bsky.social walks the walk! Thanks to Eytan Rupin for involving us! Predicting neoadjuvant breast cancer therapy response using BRIDGE from tumor transcriptomics and histopathology - Annals of Oncology www.annalsofoncology.org/article/S092...

Predicting neoadjuvant breast cancer therapy response using BRIDGE from tumor transcriptomics and histopathology

While expression-based signatures inform adjuvant therapy in breast cancer (BC), no approved molecular biomarkers exist for the neoadjuvant setting, where early response prediction could inform treatm...

annalsofoncology.org

Could not agree more! Proud to serve as an Honorary Consultant Medical Oncologist @cuh.nhs.uk since 1996!

Paul Pharoah@paulpharoah.bsky.social · last mo.

The NHS is a great institution; a national treasure. That does not mean it is without faults.

Alex Sigal and Carlos Caldas recipients of an Outstanding Researcher grant from Israel Science Foundation. This supports generously their research programs for 7 years! Picture at the President of Israel official reception. @lautenbergc.bsky.social and @hebrewuniversity.bsky.social are amazing!

Great group picture from the recent Joint Berlin–Jerusalem Symposium. Colleagues from @mdc-bimsb.bsky.social, @hadassahorg.bsky.social, @lautenbergc.bsky.social, and @hebrewuniversity.bsky.social coming together to discuss cancer science and therapy. @caldaslab.bsky.social honoured to participate!

Fantastic meeting @mdc-bimsb.bsky.social in collaboration with @hebrewuniversity.bsky.social and @hadassahorg.bsky.social! @caldaslab.bsky.social present and establishing new collaborations! Stunning building also!

@lautenbergc.bsky.social on level 4 is starting to 'gel' as young scientists interact and also celebrate! @hebrewuniversity.bsky.social This time it was Daniel from Alex Sigal's lab! @caldaslab.bsky.social is of course present and enjoying the cakes 🙂

@caldaslab.bsky.social has always been committed to supporting women leaders in science!

Carlos Caldas 🇵🇹🇮🇱🇪🇺🇬🇧@carloscaldas1960.bsky.social · 2mo ago

Following @yardenasamuels.bsky.social we now have @johannajoyce.bsky.social as @helloeacr.bsky.social President. Great leaders, advocates for women and amazing scientists! Privileged to be friends with both! European cancer research leads the way!

@helloeacr.bsky.social rocks! After 12 years on the Board time for @carloscaldas1960.bsky.social to step down and become just a regular member. What a privilege it was to serve this amazing organisation championing outstanding cancer research in Europe!

EACR - European Association for Cancer Research@helloeacr.bsky.social · 2mo ago

What a wonderful week we’ve had here together in Budapest for #EACR2026! Thank you to everyone who attended, presented at and helped organise this fantastic event. Sign up here for updates about EACR 2027 in Bilbao… 👀 eacr.us5.list-manage.com/subscribe?u=...

It's coming! @caldaslab.bsky.social will be represented! www.mdc-berlin.de/news/events/...

Joint Berlin – Jerusalem Symposium for Cancer Research and Clinical Oncology – 2026

mdc-berlin.de

Following @yardenasamuels.bsky.social we now have @johannajoyce.bsky.social as @helloeacr.bsky.social President. Great leaders, advocates for women and amazing scientists! Privileged to be friends with both! European cancer research leads the way!

Ludwig Cancer Research@ludwigcancer.bsky.social · 2mo ago

Congratulations to Ludwig @unil.bsky.social’s @johannajoyce.bsky.social, who began her two-year term today as president of the European Association for Cancer Research @helloeacr.bsky.social. bit.ly/4aeMQcD #CanSky #OncoSky

Very proud to have served on the Board for 12 years and witnessed @helloeacr.bsky.social go from strength to strength! The annual Congress and our multiple Conferences are now top notch outstanding cancer research meetings in Europe!

EACR - European Association for Cancer Research@helloeacr.bsky.social · 2mo ago

The EACR Board gathered yesterday in Budapest to review the past year and look ahead to how we can continue benefiting our members and the wider cancer research community 🤩💙

Samra Turajlic is this year’s Pezcoller - EACR Translational Cancer Researcher Award winner – delivering her award lecture on Unravelling the Mysteries of Kidney Cancer – A Journey from Genetics to Immunology #EACR2026

Ayelet Erez delivers the Pezcoller-Marina Larcher Fogazzaro-EACR Women in Cancer Research Award Lecture ‘Reactivation of a Fetal Liver Metabolic Program Promotes Extrahepatic Tumorigenesis’ #EACR2026